Radiation Therapy in the Definitive Management of Oligometastatic Prostate Cancer: The Johns Hopkins Experience

[1]  P. Choyke,et al.  Novel Imaging in Detection of Metastatic Prostate Cancer , 2019, Current Oncology Reports.

[2]  T. Derlin,et al.  Patterns of Progression After 68Ga-PSMA-Ligand PET/CT-Guided Radiation Therapy for Recurrent Prostate Cancer. , 2019, International journal of radiation oncology, biology, physics.

[3]  H. Heinzer,et al.  Standard of Care Versus Metastases-directed Therapy for PET-detected Nodal Oligorecurrent Prostate Cancer Following Multimodality Treatment: A Multi-institutional Case-control Study. , 2019, European urology focus.

[4]  T. Eade,et al.  Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Detected via Prostate-specific Membrane Antigen Positron Emission Tomography. , 2018, European urology oncology.

[5]  B. Yaremko,et al.  Stereotactic Ablative Radiation Therapy for the Comprehensive Treatment of Oligometastatic Tumors (SABR-COMET): Results of a Randomized Trial , 2018, International Journal of Radiation Oncology*Biology*Physics.

[6]  Jean L Wright,et al.  Stereotactic ablative radiation therapy for oligometastatic prostate cancer delays time-to-next systemic treatment , 2018, World Journal of Urology.

[7]  E. Cortesi,et al.  30 Gy single dose stereotactic body radiation therapy (SBRT): Report on outcome in a large series of patients with lung oligometastatic disease. , 2018, Lung cancer.

[8]  Jorge Andrade,et al.  Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis , 2018, Nature Communications.

[9]  E. Goetghebeur,et al.  Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  P. Iyengar,et al.  Consolidative Radiotherapy for Limited Metastatic Non–Small-Cell Lung Cancer: A Phase 2 Randomized Clinical Trial , 2018, JAMA oncology.

[11]  F. Alongi,et al.  Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trial. , 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  T. Treasure,et al.  Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial , 2017 .

[13]  Dora H. Tao,et al.  Impact of 68Ga-PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate Cancer , 2017, The Journal of Nuclear Medicine.

[14]  H. G. van der Poel,et al.  EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer. , 2017, European urology.

[15]  K. Pienta,et al.  Oligometastatic prostate cancer: definitions, clinical outcomes, and treatment considerations , 2017, Nature Reviews Urology.

[16]  Damien Bolton,et al.  Sensitivity, Specificity, and Predictors of Positive 68Ga-Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis. , 2016, European urology.

[17]  J. Lee,et al.  Local Consolidative Therapy versus Maintenance Therapy/Observation for Patients with Oligometastatic Non-Small Cell Lung Cancer without Progression after Front-Line Systemic Therapy: Results of a Multi-Institutional Phase II Randomized Study , 2016, The Lancet. Oncology.

[18]  Henry Knipe,et al.  Oligometastases , 2016, Radiopaedia.org.

[19]  R. Weichselbaum,et al.  Clinical and molecular markers of long‐term survival after oligometastasis‐directed stereotactic body radiotherapy (SBRT) , 2016, Cancer.

[20]  Sean S. Park,et al.  Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer , 2016 .

[21]  N. V. As,et al.  Progression-free Survival Following Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Treatment-naive Recurrence: A Multi-institutional Analysis. , 2016, European urology.

[22]  K. Decaestecker,et al.  Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence , 2014, Radiation oncology.

[23]  C. Stief,et al.  Safety and feasibility of image-guided robotic radiosurgery for patients with limited bone metastases of prostate cancer. , 2013, Urologic oncology.

[24]  J. Moul,et al.  Limited value of bone scintigraphy and computed tomography in assessing biochemical failure after radical prostatectomy. , 2003, Urology.

[25]  A. Partin,et al.  Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases. , 1994, Urology.

[26]  K. Hughes,et al.  Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. , 1986, Surgery.